$HRZN
Horizon Technology Finance Corp Stock $hrzn

$hrzn Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143774924013992 Filed on April 30, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$13.27M	$12.98M
YoY Change	8.81%	-1.6%
Cost Of Revenue	$11.85M	$12.72M
YoY Change	4.67%	-11.68%
Gross Profit	-$8.217M	$9.461M
YoY Change	-1036.94%	59.41%
Gross Profit Margin	-61.92%	72.87%
Selling, General & Admin	$559.0K	$429.0K
YoY Change	2.38%	-3.6%
% of Gross Profit		4.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$559.0K	$429.0K
YoY Change	2.38%	-3.6%
Operating Profit	-$8.776M	$9.032M
YoY Change	-2751.36%	64.52%
Interest Expense	$7.940M	$8.161M
YoY Change	10.6%	14.62%
% of Operating Profit		90.36%
Other Income/Expense, Net
YoY Change
Pretax Income	-$8.776M	$9.032M
YoY Change	-2751.36%	64.52%
Income Tax	$357.0K	$379.0K
% Of Pretax Income		4.2%
Net Earnings	-$9.133M	$8.653M
YoY Change	-6108.55%	63.08%
Net Earnings / Revenue	-68.82%	66.64%
Basic Earnings Per Share	$0.36	$0.38
Diluted Earnings Per Share	-$0.26	$0.26
COMMON SHARES
Basic Shares Outstanding	35.02M	33.40M
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$113.7M	$68.80M
YoY Change	126.13%	58.01%
Cash & Equivalents	$116.9M	$71.33M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$130.4M	$85.38M
YoY Change	100.12%	48.78%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$650.1M	$713.6M
YoY Change	-9.13%	-0.23%
Other Assets
YoY Change
Total Long-Term Assets	$657.0M	$716.9M
YoY Change	-9.03%	-0.55%
TOTAL ASSETS
Total Short-Term Assets	$130.4M	$85.38M
Total Long-Term Assets	$657.0M	$716.9M
Total Assets	$787.4M	$802.3M
YoY Change	0.0%	3.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$3.011M	$3.225M
YoY Change	36.86%	-8.07%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$72.87M	$50.14M
YoY Change	69.73%
Total Short-Term Liabilities	$88.75M	$67.81M
YoY Change	55.96%	301.02%
LONG-TERM LIABILITIES
Long-Term Debt	$369.9M	$402.4M
YoY Change	-1.39%	-8.48%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$369.9M	$402.4M
YoY Change	-1.39%	-8.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$88.75M	$67.81M
Total Long-Term Liabilities	$369.9M	$402.4M
Total Liabilities	$458.6M	$470.2M
YoY Change	6.17%	2.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$152.6M	-$131.5M
YoY Change	85.71%	83.45%
Common Stock	$40.00K	$37.00K
YoY Change	17.65%	23.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$328.8M	$332.1M
YoY Change
Total Liabilities & Shareholders Equity	$787.4M	$802.3M
YoY Change	0.0%	3.09%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$9.133M	$8.653M
YoY Change	-6108.55%	63.08%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$54.29M	$4.041M
YoY Change	-1089.95%	-68.26%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid		$10.40M
YoY Change		15.02%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-8.748M	-$8.430M
YoY Change	-172.18%	-352.93%
NET CHANGE
Cash From Operating Activities	54.29M	$4.041M
Cash From Investing Activities
Cash From Financing Activities	-8.748M	-$8.430M
Net Change In Cash	45.54M	-$4.389M
YoY Change	586.38%	-127.32%
FREE CASH FLOW
Cash From Operating Activities	$54.29M	$4.041M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	765173000	usd
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	759182000	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34637343
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33534854
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34469878
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33367389
CY2024Q1	hrzn	Investment Owned Nav Percent InvestmentOwnedNavPercent	2.141	pure
CY2023Q4	hrzn	Investment Owned Nav Percent InvestmentOwnedNavPercent	2.189	pure
CY2024Q1	hrzn	Investments Nonaccrual Interest Income InvestmentsNonaccrualInterestIncome	0	usd
CY2023Q1	hrzn	Investments Nonaccrual Interest Income InvestmentsNonaccrualInterestIncome	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q1	us-gaap	Open Tax Year OpenTaxYear	2024 2023 2022 2021
CY2024Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
CY2023Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	3200000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	3510000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	3765000	usd
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-2114934
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	312 Farmington Avenue
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Farmington
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06032
CY2024Q1	dei	City Area Code CityAreaCode	860
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	35020774
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	711116000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	709085000	usd
CY2024Q1	us-gaap	Cash Cash	46921000	usd
CY2023Q4	us-gaap	Cash Cash	46630000	usd
CY2024Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	21879000	usd
CY2023Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	26450000	usd
CY2024Q1	us-gaap	Restricted Investments RestrictedInvestments	2533000	usd
CY2023Q4	us-gaap	Restricted Investments RestrictedInvestments	2642000	usd
CY2024Q1	us-gaap	Interest Receivable InterestReceivable	16579000	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	13926000	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	3260000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	3623000	usd
CY2024Q1	us-gaap	Assets Assets	802288000	usd
CY2023Q4	us-gaap	Assets Assets	802356000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	452490000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	462235000	usd
CY2024Q1	us-gaap	Distribution Payable DistributionPayable	13099000	usd
CY2023Q4	us-gaap	Distribution Payable DistributionPayable	11011000	usd
CY2024Q1	us-gaap	Management Fee Payable ManagementFeePayable	1058000	usd
CY2023Q4	us-gaap	Management Fee Payable ManagementFeePayable	1052000	usd
CY2024Q1	us-gaap	Incentive Fee Payable IncentiveFeePayable	295000	usd
CY2023Q4	us-gaap	Incentive Fee Payable IncentiveFeePayable	0	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	3225000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	4077000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	470167000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	478375000	usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	37000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	36000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	463539000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	450949000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-131455000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-127004000	usd
CY2024Q1	hrzn	Net Assets NetAssets	332121000	usd
CY2023Q4	hrzn	Net Assets NetAssets	323981000	usd
CY2024Q1	hrzn	Liabilities And Net Assets LiabilitiesAndNetAssets	802288000	usd
CY2023Q4	hrzn	Liabilities And Net Assets LiabilitiesAndNetAssets	802356000	usd
CY2024Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	9.64
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	9.71
CY2024Q1	hrzn	Investment Company Investment Income Net InvestmentCompanyInvestmentIncomeNet	26129000	usd
CY2023Q1	hrzn	Investment Company Investment Income Net InvestmentCompanyInvestmentIncomeNet	28037000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	8161000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	7120000	usd
CY2024Q1	us-gaap	Management Fee Expense ManagementFeeExpense	3162000	usd
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	3201000	usd
CY2024Q1	hrzn	Performance Based Incentive Fee PerformanceBasedIncentiveFee	295000	usd
CY2023Q1	hrzn	Performance Based Incentive Fee PerformanceBasedIncentiveFee	2978000	usd
CY2024Q1	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	433000	usd
CY2023Q1	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	440000	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	665000	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	658000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	429000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	445000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	13145000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	14842000	usd
CY2024Q1	us-gaap	Net Investment Income NetInvestmentIncome	12984000	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	13195000	usd
CY2024Q1	us-gaap	Investment Income Operating Tax Expense Benefit InvestmentIncomeOperatingTaxExpenseBenefit	379000	usd
CY2023Q1	us-gaap	Investment Income Operating Tax Expense Benefit InvestmentIncomeOperatingTaxExpenseBenefit	184000	usd
CY2024Q1	us-gaap	Investment Income Operating After Expense And Tax InvestmentIncomeOperatingAfterExpenseAndTax	12605000	usd
CY2023Q1	us-gaap	Investment Income Operating After Expense And Tax InvestmentIncomeOperatingAfterExpenseAndTax	13011000	usd
CY2024Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	8000	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-168000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3960000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-7537000	usd
CY2024Q1	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	-3952000	usd
CY2023Q1	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	-7705000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	8653000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	5306000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.46
CY2024Q1	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.26
CY2023Q1	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.19
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.38
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.33
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33579743
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28227100
CY2022Q4	us-gaap	Assets Net AssetsNet	318448000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7174000	usd
CY2023Q1	us-gaap	Investment Income Operating After Expense And Tax InvestmentIncomeOperatingAfterExpenseAndTax	13011000	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-168000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-7537000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	218000	usd
CY2023Q1	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	9463000	usd
CY2023Q1	us-gaap	Assets Net AssetsNet	321683000	usd
CY2023Q4	us-gaap	Assets Net AssetsNet	323981000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11972000	usd
CY2024Q1	us-gaap	Investment Income Operating After Expense And Tax InvestmentIncomeOperatingAfterExpenseAndTax	12605000	usd
CY2024Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	8000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3960000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	619000	usd
CY2024Q1	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	13104000	usd
CY2024Q1	us-gaap	Assets Net AssetsNet	332121000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	8653000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	5306000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	393000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	478000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	8000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-168000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3960000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-7537000	usd
CY2024Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	23319000	usd
CY2023Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	47008000	usd
CY2024Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Securities Operating Activities ProceedsFromMaturitiesPrepaymentsAndCallsOfSecuritiesOperatingActivities	19643000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Securities Operating Activities ProceedsFromMaturitiesPrepaymentsAndCallsOfSecuritiesOperatingActivities	39756000	usd
CY2024Q1	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	1382000	usd
CY2023Q1	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	1204000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	41000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	6520000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	1695000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-840000	usd
CY2024Q1	hrzn	Increase Decrease In Endofterm Payments IncreaseDecreaseInEndoftermPayments	958000	usd
CY2023Q1	hrzn	Increase Decrease In Endofterm Payments IncreaseDecreaseInEndoftermPayments	1017000	usd
CY2024Q1	hrzn	Increase Decrease In Unearned Income IncreaseDecreaseInUnearnedIncome	952000	usd
CY2023Q1	hrzn	Increase Decrease In Unearned Income IncreaseDecreaseInUnearnedIncome	1148000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-216000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-98000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-852000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	824000	usd
CY2024Q1	us-gaap	Increase Decrease In Management Fee Payable IncreaseDecreaseInManagementFeePayable	6000	usd
CY2023Q1	us-gaap	Increase Decrease In Management Fee Payable IncreaseDecreaseInManagementFeePayable	-6000	usd
CY2024Q1	us-gaap	Increase Decrease In Incentive Fee Payable IncreaseDecreaseInIncentiveFeePayable	295000	usd
CY2023Q1	us-gaap	Increase Decrease In Incentive Fee Payable IncreaseDecreaseInIncentiveFeePayable	1586000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4041000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12730000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11972000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7174000	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	10000000	usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	10000000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	-0	usd
CY2024Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	19000	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	10397000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	9039000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8430000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3333000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4389000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	16063000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	75722000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	30466000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	71333000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	46529000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	7565000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	6623000	usd
CY2024Q1	hrzn	Refinanced Debt Investment Balances RefinancedDebtInvestmentBalances	11250000	usd
CY2023Q1	hrzn	Refinanced Debt Investment Balances RefinancedDebtInvestmentBalances	0	usd
CY2024Q1	hrzn	Warrant Investments Received And Recorded As Unearned Income WarrantInvestmentsReceivedAndRecordedAsUnearnedIncome	128000	usd
CY2023Q1	hrzn	Warrant Investments Received And Recorded As Unearned Income WarrantInvestmentsReceivedAndRecordedAsUnearnedIncome	141000	usd
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	13099000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	9365000	usd
CY2024Q1	hrzn	Endofterm Payments Receivable Noncash Transaction EndoftermPaymentsReceivableNoncashTransaction	12774000	usd
CY2023Q1	hrzn	Endofterm Payments Receivable Noncash Transaction EndoftermPaymentsReceivableNoncashTransaction	10799000	usd
CY2024Q1	us-gaap	Other Significant Noncash Transaction Value Of Consideration Received1 OtherSignificantNoncashTransactionValueOfConsiderationReceived1	4103000	usd
CY2023Q1	us-gaap	Other Significant Noncash Transaction Value Of Consideration Received1 OtherSignificantNoncashTransactionValueOfConsiderationReceived1	3944000	usd
CY2024Q1	us-gaap	Cash Cash	46921000	usd
CY2023Q1	us-gaap	Cash Cash	19844000	usd
CY2024Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	21879000	usd
CY2023Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	23698000	usd
CY2024Q1	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	2533000	usd
CY2023Q1	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	2987000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	71333000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46529000	usd
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	765173000	usd
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	711116000	usd
CY2024Q1	hrzn	Percentage Of Nonqualifying Assets On A Cost Basis PercentageOfNonqualifyingAssetsOnACostBasis	0.049	pure
CY2024Q1	hrzn	Percentage Of Nonqualifying Assets On A Fair Value Basis PercentageOfNonqualifyingAssetsOnAFairValueBasis	0.015	pure
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	759182000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	709085000	usd
CY2023Q4	hrzn	Percentage Of Nonqualifying Assets On A Cost Basis PercentageOfNonqualifyingAssetsOnACostBasis	0.047	pure
CY2023Q4	hrzn	Percentage Of Nonqualifying Assets On A Fair Value Basis PercentageOfNonqualifyingAssetsOnAFairValueBasis	0.027	pure
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 11pt;"><b><i>Use of estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:18pt;">In preparing the consolidated financial statements in accordance with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the balance sheet and income and expenses for the period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the valuation of investments.</p>
CY2024Q1	hrzn	Investment Income Attributable To Noncash Paidinkind Interest Percent InvestmentIncomeAttributableToNoncashPaidinkindInterestPercent	0.053	pure
CY2023Q1	hrzn	Investment Income Attributable To Noncash Paidinkind Interest Percent InvestmentIncomeAttributableToNoncashPaidinkindInterestPercent	0.043	pure
CY2024Q1	hrzn	Investment Nonaccrual Income Not Received In Cash Percent InvestmentNonaccrualIncomeNotReceivedInCashPercent	0.068	pure
CY2023Q1	hrzn	Investment Nonaccrual Income Not Received In Cash Percent InvestmentNonaccrualIncomeNotReceivedInCashPercent	0.063	pure
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5400000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5800000	usd
CY2024Q1	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	5600000	usd
CY2023Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	5200000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	400000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	500000	usd
CY2024Q1	hrzn	Federal Excise Tax Percent FederalExciseTaxPercent	0.04	pure
CY2024Q1	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	400000	usd
CY2023Q1	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	200000	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	167465
	hrzn	Stock Repurchased During Period Per Share StockRepurchasedDuringPeriodPerShare	11.22
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1900000	usd
CY2024Q1	us-gaap	Management Fee Expense ManagementFeeExpense	3200000	usd
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	765173000	usd
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	711116000	usd
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	759182000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	709085000	usd
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	765173000	usd
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	711116000	usd
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	759182000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	709085000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	706858000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	23319000	usd
CY2024Q1	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Warrants And Equity Received FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetWarrantsAndEquityReceived	128000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	19643000	usd
CY2024Q1	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Payment Inkind Interest FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPaymentInkindInterest	1382000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	41000	usd
CY2024Q1	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Realized Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings	21000	usd
CY2024Q1	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Appreciation Depreciation Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAppreciationDepreciationIncludedInEarnings	-2903000	usd
CY2024Q1	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Between Investments FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersBetweenInvestments	0	usd
CY2024Q1	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Other Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOtherPeriodIncreaseDecrease	825000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	709946000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	716319000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	47008000	usd
CY2023Q1	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Warrants And Equity Received FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetWarrantsAndEquityReceived	141000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	39756000	usd
CY2023Q1	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Payment Inkind Interest FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPaymentInkindInterest	1204000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	6520000	usd
CY2023Q1	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Realized Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings	-134000	usd
CY2023Q1	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Appreciation Depreciation Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAppreciationDepreciationIncludedInEarnings	-5867000	usd
CY2023Q1	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Between Investments FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersBetweenInvestments	0	usd
CY2023Q1	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Other Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOtherPeriodIncreaseDecrease	1012000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	713407000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0	usd
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	615000000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	456000000	usd
CY2024Q1	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	159000000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	615000000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	466000000	usd
CY2023Q4	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	149000000	usd
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	615000000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	452490000	usd
CY2024Q1	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	159000000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	615000000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	462235000	usd
CY2023Q4	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	149000000	usd
CY2024Q1	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability	168236000	usd
CY2024Q1	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Amount Liability FairValueDisclosureOffbalanceSheetRisksAmountLiability	1787000	usd
CY2023Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability	180500000	usd
CY2023Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Amount Liability FairValueDisclosureOffbalanceSheetRisksAmountLiability	2033000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.38
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	5199000	usd
CY2024Q1	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	24315
	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	273000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.37
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	41881000	usd
	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	145743
	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	1833000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.33
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2024Q1	us-gaap	Earnings Per Share Basic Undistributed EarningsPerShareBasicUndistributed	1.3
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	9.71
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	11.47
CY2024Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.38
CY2023Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.46
CY2024Q1	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0
CY2023Q1	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.01
CY2024Q1	hrzn	Investment Company Investment Depreciation Appreciation Per Share InvestmentCompanyInvestmentDepreciationAppreciationPerShare	-0.12
CY2023Q1	hrzn	Investment Company Investment Depreciation Appreciation Per Share InvestmentCompanyInvestmentDepreciationAppreciationPerShare	-0.26
CY2024Q1	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.26
CY2023Q1	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.19
CY2024Q1	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.38
CY2023Q1	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.33
CY2024Q1	hrzn	Investment Company Distribution To Shareholders Per Share Net Investment Income InvestmentCompanyDistributionToShareholdersPerShareNetInvestmentIncome	-0.38
CY2023Q1	hrzn	Investment Company Distribution To Shareholders Per Share Net Investment Income InvestmentCompanyDistributionToShareholdersPerShareNetInvestmentIncome	-0.33
CY2024Q1	hrzn	Investment Company Distribution To Shareholders Per Share Net Realized Gain On Investments InvestmentCompanyDistributionToShareholdersPerShareNetRealizedGainOnInvestments	0
CY2023Q1	hrzn	Investment Company Distribution To Shareholders Per Share Net Realized Gain On Investments InvestmentCompanyDistributionToShareholdersPerShareNetRealizedGainOnInvestments	0
CY2024Q1	us-gaap	Investment Company Tax Return Of Capital Distribution Per Share InvestmentCompanyTaxReturnOfCapitalDistributionPerShare	0
CY2023Q1	us-gaap	Investment Company Tax Return Of Capital Distribution Per Share InvestmentCompanyTaxReturnOfCapitalDistributionPerShare	0
CY2024Q1	hrzn	Investment Company Distribution To Shareholders Per Share Other InvestmentCompanyDistributionToShareholdersPerShareOther	0.05
CY2023Q1	hrzn	Investment Company Distribution To Shareholders Per Share Other InvestmentCompanyDistributionToShareholdersPerShareOther	0.01
CY2024Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	9.64
CY2023Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	11.34
CY2023Q4	us-gaap	Share Price SharePrice	13.17
CY2022Q4	us-gaap	Share Price SharePrice	11.6
CY2024Q1	us-gaap	Share Price SharePrice	11.37
CY2023Q1	us-gaap	Share Price SharePrice	11.28
CY2024Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.112	pure
CY2023Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.001	pure
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34469878
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28377357
CY2024Q1	us-gaap	Investment Company Expense Ratio Excluding Incentive Fee InvestmentCompanyExpenseRatioExcludingIncentiveFee	0.157	pure
CY2023Q1	us-gaap	Investment Company Expense Ratio Excluding Incentive Fee InvestmentCompanyExpenseRatioExcludingIncentiveFee	0.148	pure
CY2024Q1	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.004	pure
CY2023Q1	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.037	pure
CY2024Q1	us-gaap	Investment Company Expense Ratio Including Incentive Fee InvestmentCompanyExpenseRatioIncludingIncentiveFee	0.161	pure
CY2023Q1	us-gaap	Investment Company Expense Ratio Including Incentive Fee InvestmentCompanyExpenseRatioIncludingIncentiveFee	0.185	pure
CY2024Q1	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.154	pure
CY2023Q1	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.163	pure
CY2024Q1	hrzn	Net Assets NetAssets	332121000	usd
CY2023Q1	hrzn	Net Assets NetAssets	321683000	usd
CY2024Q1	hrzn	Average Net Assets AverageNetAssets	328051000	usd
CY2023Q1	hrzn	Average Net Assets AverageNetAssets	320066000	usd
CY2024Q1	hrzn	Investment Company Average Debt Per Share InvestmentCompanyAverageDebtPerShare	13.61
CY2023Q1	hrzn	Investment Company Average Debt Per Share InvestmentCompanyAverageDebtPerShare	15.61
CY2024Q1	hrzn	Investment Company Portfolio Turnover Ratio InvestmentCompanyPortfolioTurnoverRatio	0.014	pure
CY2023Q1	hrzn	Investment Company Portfolio Turnover Ratio InvestmentCompanyPortfolioTurnoverRatio	0.042	pure

Files In Submission

Name	View Source	Status
0001437749-24-013992-index-headers.html	Edgar Link	pending
0001437749-24-013992-index.html	Edgar Link	pending
0001437749-24-013992.txt	Edgar Link	pending
0001437749-24-013992-xbrl.zip	Edgar Link	pending
ex_634391.htm	Edgar Link	pending
ex_634392.htm	Edgar Link	pending
ex_634393.htm	Edgar Link	pending
ex_634394.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hrzn-20240331.xsd	Edgar Link	pending
hrzn20240331_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hrzn-20240331_cal.xml	Edgar Link	unprocessable
hrzn-20240331_def.xml	Edgar Link	unprocessable
hrzn-20240331_lab.xml	Edgar Link	unprocessable
hrzn-20240331_pre.xml	Edgar Link	unprocessable
hrzn20240331_10q_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HRZN
Horizon Technology Finance Corp Stock $hrzn

2024 Q2 Form 10-Q Financial Statement

#000143774924013992 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HRZN Horizon Technology Finance Corp Stock $hrzn

2024 Q2 Form 10-Q Financial Statement

#000143774924013992 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HRZN
Horizon Technology Finance Corp Stock $hrzn